Products Affected - Description
Propranolol oral tablet, Major
10 mg, unit-dose 100 count (NDC 00904-0411-61) - discontinued
Propranolol oral tablet, Teva
80 mg, 500 count (NDC 50111-0471-02)
Reason for the Shortage
- Actavis has propranolol tablets available.
- Heritage is not marketing propranolol tablets at this time.
- Northstar discontinued all propranolol tablets in February 2015.
- Mylan Institutional discontinued propranolol unit-dose tablets. The 10 mg tablets were discontinued in March 2013, the 20 mg tablets were discontinued in May 2014, and the 40 mg tablets were discontinued in January 2015.
- Qualitest refuses to provide product availability as the company considers it proprietary information.
- Teva could not provide a reason for the shortage.
- Major discontinued propranolol tablets in early 2016.
Propranolol oral tablet, Actavis
10 mg, 100 count (NDC 00591-5554-01)
10 mg, 1000 count (NDC 00591-5554-10)
20 mg, 100 count (NDC 00591-5555-01)
20 mg, 1000 count (NDC 00591-5555-10)
40 mg, 100 count (NDC 00591-5556-01)
40 mg, 1000 count (NDC 00591-5556-10)
80 mg, 100 count (NDC 00591-5557-01)
80 mg, 500 count (NDC 00591-5557-05)
Propranolol oral tablet, Mylan
10 mg, 100 count (NDC 00378-0182-01)
10 mg, 1000 count (NDC 00378-0182-10)
20 mg, 100 count (NDC 00378-0183-01)
20 mg, 1000 count (NDC 00378-0183-10)
40 mg, 100 count (NDC 00378-0184-01)
40 mg, 1000 count (NDC 00378-0184-10)
60 mg, 100 count (NDC 00378-0187-01)
80 mg, 100 count (NDC 00378-0185-01)
80 mg, 500 count (NDC 00378-0185-05)
Propranolol oral tablet, Teva
10 mg, 100 count (NDC 50111-0467-01)
10 mg, 1000 count (NDC 50111-0467-03)
20 mg, 100 count (NDC 50111-0468-01)
20 mg, 1000 count (NDC 50111-0468-03)
40 mg, 1000 count (NDC 50111-0469-03)
60 mg, 100 count (NDC 50111-0470-01)
80 mg, 100 count (NDC 50111-0471-01)
Estimated Resupply Dates
Teva has propranolol 80 mg tablets in 500 count on back order and the company estimates a release date of mid- to late-June 2016.
May 9, March 1, February 16 and 2, 2016; December 15, October 29 and 5, September 17, July 30, 13 and 2, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins